Cell surface remodeling by plasmin: a new function for an old enzyme.
about
LRP-1: a checkpoint for the extracellular matrix proteolysisEnzymatically Regulated Peptide Pairing and Catalysis for the Bioanalysis of Extracellular Prometastatic Activities of Functionally Linked EnzymesPlasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision MedicineIsothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate CancerPreparative purification of plasmin activity stimulating phenolic derivatives from Gastrodia elata using centrifugal partition chromatography.Minor Role of Plasminogen in Complement Activation on Cell Surfaces.Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.Platelet Inhibitors Reduce Rupture in a Mouse Model of Established Abdominal Aortic Aneurysm.Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease.Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.Plasminogen receptors: the first quarter century.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.Podosomes in space: macrophage migration and matrix degradation in 2D and 3D settings.Clinical models and biochemical predictors of VTE in lung cancer.Moonlighting proteins as virulence factors of pathogenic fungi, parasitic protozoa and multicellular parasites.From plasminogen to plasmin: role of plasminogen receptors in human cancer.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.Reciprocal modulation of surface expression of annexin A2 in a human umbilical vein endothelial cell-derived cell line by eicosapentaenoic acid and docosahexaenoic acid.Deciphering Key Residues Involved in the Virulence-promoting Interactions between Streptococcus pneumoniae and Human Plasminogen.In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signalingEvaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma.Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling.The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner.Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21.uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.Plasmin Prevents Dystrophic Calcification After Muscle Injury.Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
P2860
Q21285122-540871C3-37CA-45A8-82E5-835D822E0954Q27317379-25DDF169-A199-46C9-AAC6-A2CD233C0E14Q28067626-08BC1AE5-E69E-426B-AA3D-A82F01849821Q28821362-A611BB28-4B79-4339-A633-C2C8FDA63EDEQ31013475-7327B308-8C22-476E-AB5F-6D6016AF4907Q33428157-6B3F0428-D785-472B-A551-13E64F65044CQ34283594-D161CEE4-0BA4-48DD-BC53-924A1A9225FCQ35580701-F176A9D6-AD0C-4CF5-ACF2-F0B6970725D4Q35953723-DB63DE36-D289-4CA5-AE7D-86EFEA5DF8D6Q36004648-353DB9C0-619E-4900-BA74-60CECAB1272CQ36028684-638E85DB-7CD9-410B-8F6E-7F856B52B5DFQ36528166-9C67089F-012B-4763-AB9D-054A3FD331F9Q36929003-7857A472-B930-4862-AEC3-9A69AC02527CQ37207658-D9D7CA32-5089-43D3-8DC1-39BD03C6C4F6Q37609916-1532440C-04B6-4685-8971-E9FF8898753AQ38198582-8A98EB69-99AB-4A86-B54B-24104E29A99CQ38203114-D1E5F675-D071-49A1-A3B6-472C4F17348CQ38205701-4A1C5DA1-BC4D-47E5-B6A5-6E444D4B863BQ38240717-25CB9B32-303B-4F19-86DF-B1963EA4D3BEQ38269342-8339FF4B-5FB4-402A-AD71-264A8690DAFBQ38423064-31D64302-6D83-4EEB-B468-25AE03777D8CQ38583085-47403A0F-BBA8-468B-9A5A-0BF175FD20C2Q38719374-CDB62659-DFDE-4254-8AA0-412E5A3901C3Q39030372-517A7F9E-B9ED-4E39-8A56-9A2DE02563D0Q39067705-1AB8B85C-0F12-4ACA-ACDC-B0B541CD0BF0Q39233213-877658F7-55C4-470F-852D-CDC206FEFA5EQ40042049-16592B2D-23CA-483F-9712-52F3539DB046Q41832184-3E99FBAA-0DF2-4D6E-8647-C449E71E6E12Q42516196-EFBA3A38-640D-4489-900F-BCF4ECC754D8Q47142090-DCAEA3FE-0511-4725-AACA-CB25F8667C60Q48200395-7F8A2F39-A734-4872-8B0D-F9BBFE4630FFQ48333132-44D3F588-FDC9-47CE-957F-91A8FF96A4DBQ49113984-C5446B79-45F9-482A-93F2-A39FF1D85D29Q50585983-A0197403-78BE-4B77-9E27-8E7F7989E79F
P2860
Cell surface remodeling by plasmin: a new function for an old enzyme.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cell surface remodeling by plasmin: a new function for an old enzyme.
@en
type
label
Cell surface remodeling by plasmin: a new function for an old enzyme.
@en
prefLabel
Cell surface remodeling by plasmin: a new function for an old enzyme.
@en
P2860
P921
P356
P1476
Cell surface remodeling by plasmin: a new function for an old enzyme.
@en
P2093
Elena I Deryugina
James P Quigley
P2860
P304
P356
10.1155/2012/564259
P577
2012-10-14T00:00:00Z